Clinical Trial Update: Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

This update covers a completed Phase 1/Phase 2 clinical trial evaluating prolonged-release pirfenidone for slowing the progression of chronic kidney disease. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Fibrosis

Drugs mentioned

• Esbriet (pirfenidone)

Snippet

Sponsor: University of Guadalajara | Conditions: Fibrosis, Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED